Publication Date: 1/6/2010
Glitazones (Continued)
Once daily dosing
NOT RECOMMENDED if liver disease or elevated liver lab tests (ALT), or severe CHF
First glitazone (Rezulin) was removed from the market because of rare liver failure leading to death or transplant
| Previous slide | Next slide | Back to first slide | View graphic version |
